We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about soft tissue sarcomas, a rare group of cancers affecting muscles, fat, and other connective tissues. This guide covers common types like leiomyosarcoma and liposarcoma, symptoms, diagnosis, treatment options, and prevention tips relevant for Indian readers.

Soft tissue sarcomas are a rare group of cancers that originate in the body's soft tissues. These tissues include muscles, fat, blood vessels, nerves, tendons, and the lining of joints. Unlike bone cancers (bone sarcomas), soft tissue sarcomas can develop almost anywhere in the body. In India, as globally, these cancers are not as common as some other forms of cancer, but understanding their types, symptoms, and treatment is crucial for early detection and better outcomes.
The American Cancer Society estimates that a significant number of people receive a soft tissue sarcoma diagnosis annually. While specific numbers for India may vary, the global prevalence highlights the importance of awareness. More than 60 different types of soft tissue sarcomas have been identified, each with its own characteristics and behaviour. They can occur in people of all ages, though some types are more common in children or older adults.
Soft tissue sarcomas can develop in various parts of the body. Some of the most common locations include:
The three most common types of soft tissue sarcomas are:
Leiomyosarcoma arises from smooth muscle cells, which are responsible for involuntary bodily functions like moving food through the digestive tract. It can occur almost anywhere but is most frequently found in the uterus or abdomen. Leiomyosarcoma of the uterus often develops during menopause. This type tends to be aggressive, but the outlook can be better if it develops in the limbs compared to the abdomen.
Liposarcomas develop from fat cells. They can occur in various parts of the body, but are often found in the deep soft tissues of the limbs or the retroperitoneum. Liposarcomas are considered one of the more aggressive subtypes of soft tissue sarcoma.
GISTs develop from specialized cells in the wall of the gastrointestinal tract. While they are a type of soft tissue sarcoma, they have unique characteristics and are often discussed separately due to their specific treatment approaches.
UPS is an aggressive and fast-growing cancer. It typically starts as a rapidly growing lump or tumor on or below the skin, often without causing visible changes to the skin's surface. It most commonly develops in the arms or legs.
This is the most common type of soft tissue sarcoma found in children. It develops in muscle tissue and can occur in various parts of the body, including the head, neck, urinary tract, and limbs.
These are extremely rare tumors that usually affect adolescents and young adults. They typically develop in the abdomen.
The symptoms of soft tissue sarcoma often depend on the size and location of the tumor. In many cases, the first noticeable sign is a lump or swelling that may or may not be painful. It's important to note that not all lumps are cancerous, but any new, growing, or persistent lump should be evaluated by a doctor.
Common symptoms include:
The exact cause of most soft tissue sarcomas is unknown. However, certain factors are known to increase the risk:
Diagnosing soft tissue sarcoma involves a combination of medical history, physical examination, imaging tests, and a biopsy.
Your doctor will ask about your symptoms, medical history, and any known risk factors. A physical examination will be performed to check for lumps or other abnormalities.
These tests help doctors visualize the tumor and determine its size, location, and whether it has spread:
A biopsy is essential for confirming the diagnosis and determining the specific type of sarcoma. A small sample of the tumor tissue is removed and examined under a microscope by a pathologist. There are different types of biopsies:
The biopsy results will indicate whether the cells are cancerous, the grade of the tumor (how aggressive it appears), and the specific type of sarcoma.
Treatment for soft tissue sarcoma depends on the type, size, grade, and location of the tumor, as well as the patient's overall health. A multidisciplinary team of doctors, including oncologists, surgeons, and radiation oncologists, usually develops the treatment plan.
Surgery is the primary treatment for most soft tissue sarcomas. The goal is to remove the entire tumor with clear margins (meaning no cancer cells are left behind). Depending on the location and size, this may involve removing surrounding tissues or even amputation in rare cases.
Radiation therapy uses high-energy rays to kill cancer cells or slow their growth. It may be used before surgery to shrink the tumor, after surgery to kill any remaining cancer cells, or as the main treatment if surgery is not possible.
Chemotherapy uses drugs to kill cancer cells. It is often used for more aggressive sarcomas, those that have spread, or when surgery and radiation are not effective. It can be given orally or intravenously.
Targeted therapy drugs focus on specific abnormalities within cancer cells that help them grow and survive. For GISTs, specific targeted therapies are highly effective.
Immunotherapy helps the body's immune system fight cancer. It is a newer treatment option and is being studied for its effectiveness in various sarcomas.
The outlook for individuals with soft tissue sarcomas varies significantly depending on the specific subtype, grade, stage, and location of the tumor, as well as the effectiveness of treatment. Some types, like liposarcomas and synovial sarcomas, can be more aggressive. The 5-year relative survival rate is a common measure used to assess prognosis. For instance, when soft tissue sarcoma develops in the skin or the layer just beneath it, the 10-year disease-specific survival can be as high as 90%. However, for leiomyosarcoma in major blood vessels, the 5-year survival rate can range from about 31% to 66.7%. It's crucial to discuss your individual prognosis with your medical team.
Since the exact causes of most soft tissue sarcomas are unknown, there are no definitive ways to prevent them. However, reducing exposure to known risk factors can be beneficial:
Early detection is key. Be aware of your body and report any persistent or unusual lumps, swellings, or pain to your doctor promptly. Regular health check-ups can also play a role in identifying potential issues early on.
You should consult a doctor if you notice any of the following:
Prompt medical attention can lead to earlier diagnosis and more effective treatment, significantly improving the chances of a positive outcome.
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026